ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
davo47
|
526 |
146K |
17 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
526
|
146K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
davo47
|
874 |
227K |
4 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
874
|
227K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
davo47
|
93 |
25K |
15 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
93
|
25K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 Meets Quality Specifications
|
|
davo47
|
101 |
21K |
20 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
101
|
21K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
davo47
|
2.0K |
679K |
8 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
2.0K
|
679K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
davo47
|
450 |
146K |
4 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
146K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
davo47
|
209 |
65K |
26 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
209
|
65K
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
2 |
26/04/23 |
26/04/23 |
General
|
10K
|
3.7M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
3 |
26/04/23 |
26/04/23 |
General
|
10K
|
3.7M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race continues Board renewal - appoints new Chair
|
|
davo47
|
102 |
33K |
15 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
102
|
33K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
7 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
21K
|
7.1M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
7 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
21K
|
7.1M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
davo47
|
46 |
15K |
25 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
46
|
15K
|
25
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
1 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
21K
|
7.1M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints Damian Clarke-Bruce as CEO & Managing Director
|
|
davo47
|
59 |
21K |
6 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
59
|
21K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
davo47
|
2.9K |
991K |
8 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
2.9K
|
991K
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
2 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
21K
|
7.1M
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
8 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
21K
|
7.1M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
3 |
28/11/22 |
28/11/22 |
General
|
10K
|
3.7M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race 2022 AGM Presentations
|
|
davo47
|
118 |
31K |
6 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
118
|
31K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Positive Pre-IND Guidance from FDA on Zantrene
|
|
davo47
|
58 |
15K |
5 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
58
|
15K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Positive Pre-IND Guidance from FDA on Zantrene
|
|
davo47
|
58 |
15K |
23 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
58
|
15K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Nice newspaper article
|
|
davo47
|
6 |
2.3K |
6 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
6
|
2.3K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Chief Medical Officer Appointment
|
|
davo47
|
94 |
23K |
2 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
94
|
23K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
davo47
|
2.0K |
679K |
1 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.0K
|
679K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ZIRCON Ph III Imaging Study - Positive Top-Line Results
|
|
davo47
|
44 |
15K |
2 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
44
|
15K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ZIRCON Ph III Imaging Study - Positive Top-Line Results
|
|
davo47
|
44 |
15K |
3 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
44
|
15K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Melbourne Investor Briefing Invitation
|
|
davo47
|
70 |
24K |
4 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
70
|
24K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Melbourne Investor Briefing Invitation
|
|
davo47
|
70 |
24K |
0 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
70
|
24K
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
14 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
21K
|
7.1M
|
14
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
davo47
|
2.0K |
679K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
2.0K
|
679K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Response to ASX Price Query
|
|
davo47
|
20 |
10K |
35 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
20
|
10K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
davo47
|
2.0K |
679K |
4 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
2.0K
|
679K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
11 |
17/10/22 |
17/10/22 |
General
|
10K
|
3.7M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
12 |
15/10/22 |
15/10/22 |
ASX - By Stock
|
21K
|
7.1M
|
12
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
10 |
14/10/22 |
14/10/22 |
General
|
10K
|
3.7M
|
10
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
4 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
21K
|
7.1M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
9 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
21K
|
7.1M
|
9
|
|
ASX - By Stock
|
DUN |
Re:
Ann: Anomalous Co Cu Ni & Ag XRF Values in Massive Sulphides
|
|
davo47
|
312 |
109K |
1 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
312
|
109K
|
1
|
|
ASX - Day Trading
|
|
Re:
Daytraders' Aftermarket Lounge October 6
|
|
davo47
|
44 |
11K |
2 |
06/10/22 |
06/10/22 |
ASX - Day Trading
|
44
|
11K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
12 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
21K
|
7.1M
|
12
|
|
ASX - By Stock
|
DUN |
Re:
Ann: Anomalous Co Cu Ni & Ag XRF Values in Massive Sulphides
|
|
davo47
|
312 |
109K |
4 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
312
|
109K
|
4
|
|
ASX - By Stock
|
DUN |
Re:
Ann: Anomalous Co Cu Ni & Ag XRF Values in Massive Sulphides
|
|
davo47
|
312 |
109K |
1 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
312
|
109K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Develops Improved IV Formulation of Zantrene
|
|
davo47
|
90 |
35K |
20 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
90
|
35K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates New Drug Discovery Program
|
|
davo47
|
51 |
19K |
29 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
51
|
19K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
davo47
|
35 |
12K |
14 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
35
|
12K
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
14 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
21K
|
7.1M
|
14
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
21 |
23/09/22 |
23/09/22 |
ASX - By Stock
|
21K
|
7.1M
|
21
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
davo47
|
21K |
7.1M |
4 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
21K
|
7.1M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
davo47
|
10K |
3.7M |
29 |
20/09/22 |
20/09/22 |
General
|
10K
|
3.7M
|
29
|
|